Evidence map›Paper›PMID 27477083›Full record

ReviewTranslational research : the journal of laboratory and clinical medicine2017

Does the vaginal microbiota play a role in the development of cervical cancer?

Maria Kyrgiou, Anita Mitra, Anna-Barbara Moscicki

Open access · greenAbstract readReview
In one paragraph

Review in Translational research : the journal of laboratory and clinical medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 134 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
134citing papers in PubMed, 6 pooled it
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

134 citing papers in PubMed, 6 syntheses or guidelines pooled it, 305 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Contribution ofFrontiers in cellular and infection microbiology · 2021
    Pooled it
  5. Systematic Review: The Impact of Cancer Treatment on the Gut and Vaginal Microbiome in Women With a Gynecological Malignancy.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2017
    Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Frontiers in reproductive health · 2026
    Article
  18. Review
  19. Microbiome, Human Papillomavirus and Cervical Carcinogenesis.Current topics in microbiology and immunology · 2026
    Review
  20. Article

74 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Maria KyrgiouInstitute of Reproductive and Developmental Biology, Department of Surgery & Cancer, Faculty of Medicine, Imperial College, London, UK; Queen Charlotte's & Chelsea - Hammersmith Hospital, Imperial Healthcare NHS Trust, London, UK.
Anita MitraInstitute of Reproductive and Developmental Biology, Department of Surgery & Cancer, Faculty of Medicine, Imperial College, London, UK.
Anna-Barbara MoscickiDepartment of Pediatrics, University of California, Los Angeles. Electronic address: amoscicki@mednet.ucla.edu.
Imperial College Healthcare NHS Trust · GBImperial College London · GBUniversity of California, Los Angeles · US

Funding

Natural History of HPV Infection to NeoplasiaR37CA051323 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MOSCICKI, ANNA-BARBARA · 2005 to 2014
$15.4M
NATURAL HISTORY OF HPV IN TEENS--INFECTION TO NEOPLASIAR01CA051323 · NCI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI MOSCICKI, ANNA-BARBARA NONE · 1990 to 2004
$6.0M
NCI NIH HHS R01 CA051323NCI NIH HHS R37 CA051323
6 · The paper itself

Abstract

Persistent infection with oncogenic human papillomavirus (HPV) is necessary but not sufficient for the development of cervical cancer. The factors promoting persistence as well those triggering carcinogenetic pathways are incompletely understood. Rapidly evolving evidence indicates that the vaginal microbiome (VM) may play a functional role (both protective and harmful) in the acquisition and persistence of HPV, and subsequent development of cervical cancer. The first studies examining the VM and the presence of an HPV infection using next-generation sequencing techniques identified higher microbial diversity in HPV-positive as opposed to HPV-negative women. Furthermore, there appears to be a temporal relationship between the VM and HPV infection in that specific community state types may be correlated with a higher chance of progression or regression of the infection. Studies describing the VM in women with preinvasive disease (squamous intraepithelial neoplasia [SIL]) consistently demonstrate a dysbiosis in women with the more severe disease. Although it is plausible that the composition of the VM may influence the host's innate immune response, susceptibility to infection, and the development of cervical disease, the studies to date do not prove causality. Future studies should explore the causal link between the VM and the clinical outcome in longitudinal samples from existing biobanks.

Indexed as

MicrobiotaAnimalsCarcinogenesisFemaleHumansNeoplasm InvasivenessPapillomaviridaeUterine Cervical NeoplasmsVagina

Identifiers

PMID27477083
PMCPMC5164950
OpenAlexW2491738998

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.